These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23714463)

  • 1. Connecting molecular pathways to hereditary cancer risk syndromes.
    Testa JR; Malkin D; Schiffman JD
    Am Soc Clin Oncol Educ Book; 2013; ():81-90. PubMed ID: 23714463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
    Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM
    BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
    Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z; Buljan M; Busam KJ
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
    Gill AJ
    Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
    Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
    J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
    Wang G; Rao P
    Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.
    Kadariya Y; Cheung M; Xu J; Pei J; Sementino E; Menges CW; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR
    Cancer Res; 2016 May; 76(9):2836-44. PubMed ID: 26896281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
    Pilarski R; Cebulla CM; Massengill JB; Rai K; Rich T; Strong L; McGillivray B; Asrat MJ; Davidorf FH; Abdel-Rahman MH
    Genes Chromosomes Cancer; 2014 Feb; 53(2):177-82. PubMed ID: 24243779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAPoma presenting as an incidental scalp papule: case report, literature review, and screening recommendations for BAP1 tumor predisposition syndrome.
    Zaayman M; Nguyen P; Silfvast-Kaiser A; Frieder J; West C; Tumminello K; Paek SY
    J Dermatolog Treat; 2022 Jun; 33(4):1855-1860. PubMed ID: 34106034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
    Rai K; Pilarski R; Cebulla CM; Abdel-Rahman MH
    Clin Genet; 2016 Mar; 89(3):285-94. PubMed ID: 26096145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of hereditary head and neck paragangliomas.
    Boedeker CC; Hensen EF; Neumann HP; Maier W; van Nederveen FH; Suárez C; Kunst HP; Rodrigo JP; Takes RP; Pellitteri PK; Rinaldo A; Ferlito A
    Head Neck; 2014 Jun; 36(6):907-16. PubMed ID: 23913591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDHA is a tumor suppressor gene causing paraganglioma.
    Burnichon N; Brière JJ; Libé R; Vescovo L; Rivière J; Tissier F; Jouanno E; Jeunemaitre X; Bénit P; Tzagoloff A; Rustin P; Bertherat J; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2010 Aug; 19(15):3011-20. PubMed ID: 20484225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of Real-time Integrative Sequencing in Management of Patients With Suspected Germline BAP1 Mutations.
    Sengupta S; Weyand AC; Upadhyaya SA; Wu YM; Robinson DR; Mody RJ
    J Pediatr Hematol Oncol; 2019 May; 41(4):e263-e265. PubMed ID: 29554022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
    Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
    JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Investigation of Lesions Associated with Succinate Dehydrogenase Defects.
    Taïeb D; Timmers H; Pacak K
    Horm Metab Res; 2019 Jul; 51(7):414-418. PubMed ID: 29618137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary paragangliomas.
    Raygada M; Pasini B; Stratakis CA
    Adv Otorhinolaryngol; 2011; 70():99-106. PubMed ID: 21358191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign splenic lesions in BAP1-tumor predisposition syndrome: a case series.
    Miranda J; Dave P; Kemel Y; Sheikh R; Zong G; Calderon LP; Will M; Liu YL; Walsh M; Stadler ZK; Offit K; Latham A; Mandelker D; Chen YB; Andrieu PC; Carlo MI
    Eur J Hum Genet; 2024 Aug; 32(8):1027-1031. PubMed ID: 38824259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAP1 Tumor Predisposition Syndrome Presenting as a Recurrent Ovarian Sex Cord-Stromal Tumor.
    Albright BB; Wignall E; Bentley RC; Havrilesky LJ; Previs RA; Strickland KC
    Int J Gynecol Pathol; 2023 Jan; 42(1):83-88. PubMed ID: 35348477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
    Baysal BE; Maher ER
    Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.